• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
    • Just look at what our Tens of Thousands of Satisfied Customers say about us
    Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Indian pharmaceutical market growing at fast rate

      Posted Atpr-inside.com

      The market research report 'Indian Pharma Sector Analysis-, detailed study of the Indian pharmaceutical market. It does an exhaustive investigation on the structure of the domestic pharmaceutical market and gives a thorough analysis of the driving and restraining forces operating against it.

      India has one of the fastest growing pharmaceutical markets in the world. In 2006-07, this market was valued at over US$ 7 Billion. Driven by a huge patient base, increasing incomes, improving healthcare infrastructure and strong penetration of health insurance, the pharmaceutical market is expected to grow more than double its size in the next five years. Drugs for acute diseases presently dominate this market; however, the increasing penetration of lifestyle-related diseases is expected to fuel the growth of drugs targeting chronic diseases.

      The Indian pharmaceutical market at present is highly fragmented, with the top three companies having a market share of around 5% each. However, introduction of the product patent regime is likely to result in heavy consolidation in future.

      Key Findings
      The domestic pharmaceutical market in India has grown at a CAGR of nearly 12% in the last five years.
      At present, drugs for mass therapies dominate, however, driven by an increasing prevalence of lifestyle-associated diseases, drugs for specialty therapies are expected to remain buoyant in future.
      Around 67 Million Indians are expected to be above 67 years of age by 2011. This age group spends around 3 to 4 times more on drugs than those in younger age groups, thus fuelling the market growth.
      Patented drugs, which had no share in the pharmaceutical market, are expected to have a 10% market share in 2010.
      Around 64% Indians are not covered under by health insurance and pay expenses for pharmaceuticals out of pocket.
      Driven by factors such as rising rural incomes and a strong distribution network, India's rural pharmaceutical market is experiencing a strong growth.
      The product patent regime will encourage the Indian companies to invest more in Research and Development.
      Key Issues & Facts Analyzed
      Evaluation of past, current and future market trends.
      Evaluation of the market by segment.
      Discussion about the major drivers of the pharmaceutical market.
      Analysis of the opportunities created by the market.
      Review on the government regulations on the market.
      Analysis of the major challenges faced by the market.
      Competitive landscape of the market.

      Key Players Analyzed

      This section provides the overview, key facts and financial information of prominent players in the Indian pharmaceutical market Like Ranbaxy Laboratories Limited, Cipla Limited, GlaxoSmithKline Pharmaceuticals Limited, Nicholas Piramal India Limited and Zydus Cadila.

      Research Methodology Used

      Information Sources
      Information has been sourced from books, newspapers, trade journals, and white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to more than 3000 paid databases.

      Analysis Methods
      The analysis methods include ratio analysis, historical trend analysis, linear regression analysis using software tools, judgmental forecasting, and cause and effect analysis.
      Table of Contents
      1. Analyst View
      2. Global Pharmaceutical Market
      2.1 Market Size & Growth
      2.2 Leading Therapy Classes
      2.3 Leading Pharmaceutical Companies
      2.4 Leading Drugs
      2.5 Geographical Performance
      2.6 India - The Emerging Market
      3. India - Macroecomomic & Healthcare Profile
      3.1 Macroeconomic Profile
      3.1.1 GDP
      3.1.2 Consumer Price Index
      3.1.3 Currency Fluctuation
      3.1.4 Foreign Direct Investment
      3.2 Population Profile
      3.2.1 Population
      3.2.2 Sex Ratio
      3.2.3 Age Profile
      3.3 Healthcare Profile
      3.3.1 Healthcare Spending
      3.3.2 Sources of Healthcare Payments
      3.3.3 Doctors & Nurses
      3.3.4 Hospitals & Clinics
      3.3.5 Top Causes of Mortality
      4. Indian Pharmaceutical Market
      4.1 Turnover
      4.2 Exports & Imports
      4.2.1 Exports
      4.2.2 Imports
      4.3 Bulk Drugs & Formulations
      5. Domestic Pharmaceutical Market
      5.1 Drivers
      5.1.1 Ageing Population
      5.1.2 Increasing Income
      5.1.3 Product Patent Regime
      5.1.4 Improving Medical Infrastructure
      5.1.5 Increasing Prevalence of Lifestyle-related Diseases
      5.2 Market Size & Growth
      5.3 Market Segmentation
      5.3.1 By Drugs
      5.3.1.1 Traditional Branded Generics
      5.3.1.2 Specialty Branded Generics
      5.3.1.3 Generic Generics
      5.3.1.4 Patented Drugs
      5.3.2 By Therapeutics
      5.3.2.1 Acute Segment
      5.3.2.2 Chronic Segment
      5.4 Government Regulations & Market Entry
      5.4.1 Industrial & Manufacturing License
      5.4.2 Patent Laws
      5.4.3 Research & Development
      5.4.4 Pricing
      5.4.5 Market Entry
      5.5 Opportunities
      5.5.1 For the Industry
      5.5.1.1 Biogenerics
      5.5.1.2 Rural Markets
      5.5.1.3 Cardiovascular Market
      5.5.1.4 Diabetes Market
      5.5.1.5 Asthma Market
      5.5.1.6 Obesity Market
      5.5.1.7 Oncology Market
      5.5.1.8 HIV Market
      5.5.2 By the Industry
      5.5.2.1 Contract Manufacturing
      5.5.2.2 Contract Research
      5.5.2.3 Bioinformatics
      5.5.2.4 Health Insurance
      5.5.2.5 Drug Delivery & Packaging Industries
      5.5.2.6 Pharmaceutical Retail Chains
      5.6 Challenges
      5.6.1 Lack of Innovation
      5.6.2 Drug Price Controls & Low Margins
      5.6.3 Low Per Capita Spending on Drugs
      5.6.4 Multinationals Reluctant to Invest in India
      5.6.5 Counterfeit Drugs
      5.6.6 Low Government Financing
      5.7 Future Outlook
      5.7.1 Market Drivers & Restraints
      5.7.2 Sales (2007-08 to 2011-12)
      6. Competitive Landscape
      6.1 Market Structure
      6.2 Market Share of Key Players
      6.3 Profile of Key Players
      6.3.1 Ranbaxy Laboratories Limited
      6.3.2 Cipla Limited
      6.3.3 GlaxoSmithKline Pharmaceuticals Limited
      6.3.4 Nicholas Piramal India Limited
      6.3.5 Zydus Cadila
      List of Table
      Table 2-1: Global - Leading Therapy Classes by Sale (in Billion US$), 2006
      Table 2-2: Global - Leading Drugs by Sale (in Billion US$), 2006
      Table 2-3: Global - Pharmaceutical Market by Region (in Billion US$), 2006
      Table 4-1: India - Pharmaceutical Exports to Top Countries (in Million US$), 2003-2005
      Table 4-2: India - Pharmaceutical Imports from Top Countries (in Million US$), 2003-2005
      Table 5-1: India - Share of Drugs for Acute Disorders in Domestic Pharmaceutical Market (%), 2006
      Table 5-2: India - Share of Drugs for Chronic Disorders in Domestic Pharmaceutical Market (%), 2006
      Table 5-3: India - Launch of Patented Drugs by Product & Company
      Table 5-4: India - Number of Drug Delivery Companies by Formulation Type (1999, 2003 & 2007E)
      Table 5-5: India - Expansion Plans of Pharmacy Retail Chains
      Table 5-6: India - Counterfeit Drugs in Domestic Pharmaceutical Market
      Table 6-1: India - Performance of Top 20 Pharmaceutical Companies, 2005
      Table 6-2: India - Performance of Top 20 Pharmaceutical Companies, 2006
      Table 6-3: Ranbaxy Laboratories Limited - Key Financials (in Million INR), 2004-2006
      Table 6-4: Cipla Limited - Key Financials (in Million INR), 2005-06 & 2006-07
      Table 6-5: GlaxoSmithKline Pharmaceuticals Limited - Key Financials (in Million US$), 2005 & 2006
      Table 6-6: Nicholas Piramal India Limited - Key Financials (in Million INR), 2005-06 & 2006-07
      Table 6-7: Zydus Cadila - Key Financials (in Million INR), March 2004 to March 2006
      List of Charts
      Figure 2-1: Global - Pharmaceutical Market (in Billion US$), 2001-2006
      Figure 2-2: Global - Pharmaceutical Market Growth (%), 2002-2006
      Figure 2-3: Global - Leading Pharmaceutical Companies (in Billion US$), 2006
      Figure 2-4: Global - Pharmaceutical Market by Region (%), 2006
      Figure 2-5: Global - Top Pharmaceutical Markets (in Billion US$), 2005
      Figure 2-6: Global - Forecast for Top Pharmaceutical Markets (in Billion US$), 2015
      Figure 2-7: Global - CAGR of Top Pharmaceutical Markets (%), 2005 to 2015
      Figure 3-1: India - Nominal GDP (in Million US$), 2001-2006
      Figure 3-2: India - Nominal GDP (in Million US$) 2007-2011F
      Figure 3-3: India - Consumer Price Index (%), 2001-2006
      Figure 3-4: India - Consumer Price Index (%), 2007-2011F
      Figure 3-5: India - Currency Exchange Rates (From US$ to INR), 2001-2007
      Figure 3-6: India - Foreign Direct Investment (in Billion US$), 2002-03 to 2006-07
      Figure 3-7: India - Foreign Direct Investment in Pharmaceuticals (in Million US$), 2003-04 to 2006-07
      Figure 3-8: India - Population (in Million), 2003-2006E
      Figure 3-9: India - Population (in Million), 2007-2011F
      Figure 3-10: India - Ratio of Males & Females in Population (%), 2003-2006
      Figure 3-11: India - Population Breakup by Age (%), 2003-2006E
      Figure 3-12: India - Population Breakup by Age (%), 2007-2011F
      Figure 3-13: India - Healthcare Spending per Head (in US$), 2001-2006E
      Figure 3-14: India - Healthcare Spending per Head (in US$), 2007-2011F
      Figure 3-15: India - Breakup of Healthcare Payments by Source (%), 2006
      Figure 3-16: India - Number of Doctors (in ‘000) 2005 & 2006E
      Figure 3-17: India - Number of Doctors (in ‘000), 2007-2011F
      Figure 3-18: India - Number of Nurses (in ‘000), 2004-2006E
      Figure 3-19: India - Number of Nurses (in ‘000), 2007-2011F
      Figure 3-20: India - Number of Hospital Beds (in ‘000), 2004-2006E
      Figure 3-21: India - Number of Hospital Beds (in ‘000), 2007-2011F
      Figure 3-22: India - Number of Deaths due to Leading Causes (in Numbers), 2005
      Figure 3-23: India - Leading Causes of Death (%), 2005
      Figure 3-24: India - Forecast for Leading Causes of Death (%), 2030
      Figure 4-1: India - Pharmaceutical Market Turnover* (in Billion INR), 2001-02 to 2006-07
      Figure 4-2: India - Breakup of Pharmaceutical Market (%), 2006-07
      Figure 4-3: India - Pharmaceutical Exports (in Billion INR), 2000-01 to 2006-07
      Figure 4-4: India - Major API Exports (in Billion INR), 2005-06
      Figure 4-5: India - Major Dosage Form Exports (in Billion INR), 2005-06
      Figure 4-6: India - Breakup of Pharmaceutical Exports by Region (%), 2005-06
      Figure 4-7: India - Forecast for Pharmaceutical Exports (in Billion INR), 2007-08 to 2011-12
      Figure 4-8: India - Pharmaceutical Imports (in Billion INR), 2000-01 to 2006-07E
      Figure 4-9: India - Breakup of Pharmaceutical Imports by Group (%), 2005
      Figure 4-10: India - Bulk Drugs Production* (in Billion INR), 2001-02 to 2006-07E
      Figure 4-11: India - Formulations Production* (in Billion INR), 2001-02 to 2006-07E
      Figure 5-1: India - Population of People above 65 Years (in Million), 2003 -2006E
      Figure 5-2: India - Income Distribution among Households (%), 1989-90, 2001-02 & 2006-07E
      Figure 5-3: India - Prevalence of Lifestyle Related Disorders (%), 2005
      Figure 5-4: India - Share of Mass & Specialty Therapies in Pharmaceutical Market (%), 2004, 2006 & 2015F
      Figure 5-5: India - Domestic Pharmaceutical Market (in Billion INR), 2001-02 to 2006-07
      Figure 5-6: India - Breakup of Domestic Pharmaceutical Market by Drug Category (%), 2004
      Figure 5-7: India - Forecast for Breakup of Domestic Pharmaceutical Market by Drug Category (%), 2010
      Figure 5-8: India - Traditional Branded Generics Market (in Billion US$), 2004 & 2010F
      Figure 5-9: India - Specialty Branded Generics Market (in Billion US$), 2004 & 2010F
      Figure 5-10: India - Generic Generics Market (in Billion US$), 2004 & 2010F
      Figure 5-11: India - Patented Drugs Market (in Billion US$), 2004 & 2010F
      Figure 5-12: India - Breakup of Domestic Pharmaceutical Market by Therapeutic Category (%), 2006
      Figure 5-13: India - Breakup of Drugs for Acute & Chronic Diseases in Domestic Pharmaceutical Market (%), 2006
      Figure 5-14: Global - Biogenerics Market (in Million US$), 2006 & 2011F
      Figure 5-15: India - Breakup of Pharmaceutical Market by Geographical Tier (%), 2005
      Figure 5-16: India - Forecast for Breakup of Pharmaceutical Market by Geographical Tier (%), 2011
      Figure 5-17: India - Number of Coronary Heart Patients (in Million), 2005 & 2015F
      Figure 5-18: India - Cardiovascular Market (in Billion INR) 2005, 2006 & 2010F
      Figure 5-19: India - Number of Diabetes Patients (in Million), 2005 & 2015F
      Figure 5-20: India - Anti-diabetic Market (in Billion INR) 2005, 2006 & 2010F
      Figure 5-21: India - Number of Asthma Patients (in Million), 2005 & 2015F
      Figure 5-22: India - Anti-asthma Market (in Billion INR), 2002, 2006 & 2010F
      Figure 5-23: India - Number of Obese Patients (in Million), 2005 & 2015F
      Figure 5-24: India - Anti-obesity Pills Market (in Million INR), 2006 & 2010F
      Figure 5-25: India - Number of Cancer Patients (in Million), 2005 & 2015F
      Figure 5-26: India - Oncology Market (in Billion INR), 2005, 2006 & 2010F
      Figure 5-27: India - Prevalence of HIV (%), 2002 & 2007
      Figure 5-28: India - AIDS/HIV Drugs Market (in Million INR), 2001, 2006 & 2010F
      Figure 5-29: Global - Countries with Maximum Number of US FDA Approved Manufacturing Plants, 2005
      Figure 5-30: India - Contract Manufacturing Market (in Million US$), 2005-2010F
      Figure 5-31: India - CRO Industry (in Million US$), 2006 & 2010F
      Figure 5-32: India - Bioinformatics Market (in Million US$), 2002-03 to 2006-07 & 2011-12F
      Figure 5-33: India - Health Insurance Market (in Billion INR), 2001-02, 2006-07 & 2011-12F
      Figure 5-34: India - Drug Packaging Market (in Billion INR), 2006-07 & 2011-12F
      Figure 5-35: India & Global - Proportion of Revenue Spent on R&D (%), 2005
      Figure 5-36: India - Spending on R&D (in Million US$), 2000-01 to 2005-06
      Figure 5-37: Global - Per Capita Drug Consumption of Top Pharmaceutical Markets (in US$), 2006
      Figure 5-38: Global - Share of State & Personal Financing in Top Pharmaceutical Markets (%), 2006
      Figure 5-39: India - Income Distribution among Households (%), 2006-07 & 2011-12F
      Figure 5-40: India - Forecast for Prevalence of Lifestyle Related Disorders (%), 2015
      Figure 5-41: India - Population of People above 65 Years (in Million), 2007-2011F
      Figure 5-42: India - Forecast for Domestic Pharmaceutical Market (in Billion INR), 2007-08 to 2011-12
      Figure 6-1: India - Share of Companies in Pharmaceutical Market (%), 2006

      January 13, 2008

       

      Share this Article!

    Back to top^